Haemonetics (HAE) Tops Q2 EPS by 16c; offers guidance
Get Alerts HAE Hot Sheet
Price: $119.65 --0%
Revenue Growth %: +5.6%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
AES, SYRS, ZVOI, More
Revenue Growth %: +5.6%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
AES, SYRS, ZVOI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $1.27, $0.16 better than the analyst estimate of $1.11. Revenue for the quarter came in at $327 million versus the consensus estimate of $311.46 million.
GUIDANCE:
Haemonetics sees FY2026 EPS of $4.80-$5.00, versus the consensus of $4.83.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tower Semiconductor (TSEM) Misses Q3 EPS by 1c ; Offers Guidance
- Choice Hotels (CHH) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
- TFI International (TFII) PT Lowered to $107 at Stifel Amid U.S. LTL Execution Challenges
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share